On the other hand, being the potent oncogene FoxM1, another member of the Forkhead family, negatively regulated by FoxO3a [42], its increased expression in more invasive and endocrine-resistant tumors [43,44], perfectly fits with the evidence of a defective FoxO3a in this subset of cancers. This evidence concerns the gene FOXO3 and cancer.